In this brief monologue, Bryan Johnson explains that he is fasted and prepared for a blood draw that will measure 63 biomarkers. He describes using multiple types of collection tubes, with some samples processed in-house by a doctor partner and others shipped to specialized external labs. He notes that this draw will require roughly 15 vials, a significant reduction from the initial Blueprint draw, which involved about 50 vials.
So I'm fasted. I'm ready for the blood draw. We're doing 63 biomarkers with blood. We have these different tubes for the various tests. Then I'll sit over here to get the other blood draw. A doctor partner of ours uses in house capabilities to process some of the blood. They ship out some of the samples to other groups who do specialized processing. These are also specialized tests that we're looking at today will be more blood than normal because we're doing 63 biomarkers, which is quite a few. It is a lot better than we were before. When we first started Blueprint, I think our first blood draw, which I have a picture of, we had around 50 vials and it was a huge draw. This time I'm guessing we'll probably be in the range of 15 or so.
